Treatment Pattern and Overall Survival in Newly Diagnosed Multiple Myeloma Patients who are not Eligible for Autologous Stem Cell Transplantation

被引：0
|
作者：
He, Jianming [1 ]
Qiu, Lugui [2 ]
Schmerold, Luke [3 ]
Potluri, Ravi [3 ]
Li, Lin [4 ]
Hu, Peter [5 ]
Nemat, Sepideh [6 ]
Smugar, Steven S. [7 ]
Appiani, Carlos [8 ]
Mehra, Maneesha [9 ]
Richarz, Ute [10 ]
机构：
[1] Janssen, Raritan, NJ USA
[2] Chinese Acad Med Sci, Inst Hematol, Tianjin, Peoples R China
[3] Smart Analyst, New York, NY USA
[4] Xian Janssen Pharmaceut Ltd, Beijing, Peoples R China
[5] Janssen R&D, Raritan, NJ USA
[6] Janssen R&D, High Wycombe, Bucks, England
[7] Janssen R&D, Titusville, NJ USA
[8] Janssen R&D, Spring House, PA USA
[9] Janssen Global Serv, Raritan, NJ USA
[10] Janssen Global Serv, Zug, Switzerland
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2019年 / 19卷 / 10期
关键词：
Multiple myeloma; multiple myeloma-specific survival; multiple-myeloma specific survival;
D O I：
10.1016/j.clml.2019.09.380
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SP-054
引用
收藏
页码：E229 / E229
页数：1
相关论文
共 50 条
  • [1] Advances in maintenance strategy in newly diagnosed multiple myeloma patients eligible for autologous transplantation
    Wahab, Ahsan
    Rafae, Abdul
    Faisal, Muhammad Salman
    Mushtaq, Kamran
    Ehsan, Hamid
    Khakwani, Maria
    Ashraf, Afia
    Rehan, Tayyab
    Ahmed, Zahoor
    Shah, Zunairah
    Khan, Aslam
    Anwer, Faiz
    EXPERT REVIEW OF HEMATOLOGY, 2020, 13 (12) : 1333 - 1347
  • [2] Treatment of Newly Diagnosed Myeloma in Patients not Eligible for Transplantation
    Victoria Mateos, M.
    San-Miguel, Jesus
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2011, 6 (02) : 113 - 119
  • [3] Treatment of Newly Diagnosed Myeloma in Patients not Eligible for Transplantation
    M. Victoria Mateos
    Jesús San-Miguel
    Current Hematologic Malignancy Reports, 2011, 6 : 113 - 119
  • [4] A Phase II trial of weekly bortezomib and dexamethasone in veterans with newly diagnosed multiple myeloma not eligible for or who deferred autologous stem cell transplantation
    Girnius, Saulius K.
    Lee, Saem
    Kambhampati, Suman
    Rose, Michal G.
    Mohiuddin, Abid
    Houranieh, Antoun
    Zimelman, Abraham
    Grady, Terrence
    Mehta, Paulette
    Behler, Caroline
    Hayes, Teresa G.
    Efebera, Yvonne A.
    Prabhala, Rao H.
    Han, Andrew
    Yellapragada, Sarvari V.
    Klein, Catherine E.
    Roodman, Garson D.
    Lichtenstein, Alan
    Munshi, Nikhil C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 169 (01) : 36 - 43
  • [5] Identification of clinical-biological features of newly diagnosed early relapse multiple myeloma patients eligible for autologous stem cell transplantation
    Cillo, Lorenzo
    Dalla Palma, Anna Benedetta
    Ricci, Stefania
    Pedrazzoni, Mario
    Scita, Matteo
    Bernardi, Matia
    Sammarelli, Gabriella
    Pelagatti, Laura
    Giuliani, Nicola
    EJHAEM, 2024, 5 (04): : 892 - 895
  • [6] Young age and autologous stem cell transplantation are associated with improved survival in newly diagnosed multiple myeloma
    Bove, Virginia
    Garrido, David
    Riva, Eloisa
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2021, 43 (03) : 295 - 302
  • [7] Early response-based intensification of primary therapy in newly diagnosed multiple myeloma patients who are eligible for autologous stem cell transplantation: phase II study
    Ahn, Seo-Yeon
    Jung, Sung-Hoon
    Joo, Young Don
    Lee, Won Sik
    Lee, Sang Min
    Choi, Chul Won
    Kim, Seok Jin
    Kim, Kihyun
    Lee, Je-Jung
    ANNALS OF HEMATOLOGY, 2014, 93 (09) : 1571 - 1577
  • [8] Early response-based intensification of primary therapy in newly diagnosed multiple myeloma patients who are eligible for autologous stem cell transplantation: phase II study
    Seo-Yeon Ahn
    Sung-Hoon Jung
    Young Don Joo
    Won Sik Lee
    Sang Min Lee
    Chul Won Choi
    Seok Jin Kim
    Kihyun Kim
    Je-Jung Lee
    Annals of Hematology, 2014, 93 : 1571 - 1577
  • [9] Impact of duration of induction therapy on survival in newly diagnosed multiple myeloma patients undergoing upfront autologous stem cell transplantation
    Chakraborty, Rajshekhar
    Muchtar, Eli
    Kumar, Shaji K.
    Buadi, Francis K.
    Dingli, David
    Dispenzieri, Angela
    Hayman, Suzanne R.
    Hogan, William J.
    Kapoor, Prashant
    Lacy, Martha Q.
    Leung, Nelson
    Warsame, Rahma
    Kourelis, Taxiarchis
    Gonsalves, Wilson
    Gertz, Morie A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 182 (01) : 71 - 77
  • [10] Autologous stem cell transplantation for elderly patients with newly diagnosed multiple myeloma in the era of novel agents
    Merz, M.
    Neben, K.
    Raab, M. S.
    Sauer, S.
    Egerer, G.
    Hundemer, M.
    Hose, D.
    Kunz, C.
    Heiss, C.
    Ho, A. D.
    Goldschmidt, H.
    Hillengass, J.
    ANNALS OF ONCOLOGY, 2014, 25 (01) : 189 - 195
12345